The Pipeline Crisis

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-01-02-2005, Volume 29, Issue 1

Committees make prudent decisions and avoid mistakes, but they're afraid of the new.

Related Content:

Bio/Pharma BusinessFrom the EditorViewpointsPharmaceutical Technology-01-02-2005
Charles River to Provide pDNA Manufacturing Services in Two Deals
Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy
Genmab Expands ADC Pipeline with $1.8 Billion Acquisition of ProfoundBio